Question 1

What is Asset42?

Accepted Answer

Asset42 (Ontosight) is a pharmaceutical asset intelligence platform for drug in-licensing, drug out-licensing, BD asset search, and pipeline discovery with AI-assisted workflows.

Question 2

Who is Asset42 for?

Accepted Answer

Pharma and biotech business development teams running drug in-licensing and out-licensing programs—search & evaluation and partnering teams who need discoverable assets, structured analysis, and faster decisions.

Question 3

How do I explore licensing opportunities?

Accepted Answer

Use the public navigation links for drug in-licensing (search), drug out-licensing, and R&D Capabilities (AI Drug Discovery Suite and validation)—each section has a dedicated URL for sharing and indexing.

Smarter Licensing.Faster Discovery.AI drug asset exchange

In-licensing

Out-licensing

R&D Capabilities

Smarter Licensing. Faster Discovery.AI drug asset exchange

Smarter Licensing.Faster Discovery.AI drug asset exchange

In-licensing

Out-licensing

R&D Capabilities

Smarter Licensing. Faster Discovery.AI drug asset exchange

In-licensing

AI drug asset exchange for in-licensing discovery

Out-licensing

AI-assisted out-licensing deal sourcing

R&D Capabilities

Drug discovery and licensing intelligence capabilities